Knock-Down of IL-1Ra in Obese Mice Decreases Liver Inflammation and Improves Insulin Sensitivity

• Niclas Franck,

  Affiliation Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Michael Maris,

  Affiliations Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, United States of America, Clinical and Experimental Endocrinology, Catholic University Leuven, Leuven, Belgium

  ⨯
• Sarah Nalbandian,

  Affiliation Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Saswata Talukdar,

  Affiliation Pfizer Inc. Research Laboratories, Cambridge, Massachusetts, United States of America

  ⨯
• Simon Schenk,

  Affiliation Department of Orthopedic Surgery, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Hans-Peter Hofmann,

  Affiliation Pfizer Inc. Research Laboratories, Cambridge, Massachusetts, United States of America

  ⨯
• David Bullough,

  Affiliation Pfizer Inc. Research Laboratories, Cambridge, Massachusetts, United States of America

  ⨯
• Olivia Osborn

  * E-mail: oosborn@ucsd.edu

  Affiliation Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, United States of America

  ⨯